Bal Pharma Limited has withdrawn its application for the reclassification of promoter Ms. Anita Chandraprakash Siroya. This decision comes after discussions with the listing compliance teams of BSE and NSE, considering that she holds more than 10% of the voting rights in the company, which is governed by Regulation 31A of the SEBI (LODR) Regulations. This move maintains the existing promoter structure, which could have implications for governance and shareholder dynamics. Investors should monitor any further developments regarding promoter classifications and potential impacts on ownership structure.